AzTrials
AzTrials

Domestic ViolenceNCT01372098

Nurse-family Partnership (NFP) Curriculum Study

A study testing NFP + IPV intervention in people with Domestic Violence, run by McMaster University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether the Intimate Partner Violence (IPV) intervention in the context of Nurse-Family Partnership (NFP) program improves women's quality of life and reduces violence relative to the NFP alone using a cluster randomized controlled trial. Read more about this study

Who is it for?
Ages 16 years and older, women only
Conditions the study is for
Domestic Violence
What is being tested?
NFP + IPV intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
492 participants
Where
1 siteUnited States
Study dates
May 2011to May 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Age 16 years and older
  • NFP program participants (woman with first live birth and living in poverty)
  • English speaker

Who cannot join

  • Woman who cannot communicate in English

Trial locations and contacts

1 site in 1 country.

United States1 site
  • 600 S. Commonwealth Ave., #800

    Los Angeles, California, 90005

Other trials in United States

About this study

Official title: Development and Evaluation of an Intervention for Intimate Partner Violence in the Context of Nurse Home Visits

The purpose of this study is to determine whether the Intimate Partner Violence (IPV) intervention in the context of Nurse-Family Partnership (NFP) program improves women's quality of life and reduces violence relative to the NFP alone using a cluster randomized controlled trial. Our hypothesis is that an IPV intervention can be designed that is acceptable to participants in the NFP, feasible to implement, and that this intervention will improve quality of life for women and reduce exposure to violence.

Being tested
NFP + IPV intervention
Keywords
Domestic Violence, Spouse Abuse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NFP + IPV interventionBehavioural

    The intervention focuses on helping women stay safe in a relationship. Strategies for overcoming barriers to using and accessing community resources and services, and community agency interventions for women exposed to IPV is built into the intervention.

Study groups in NCT01372098
Study groupRoleWhat they receive
NFP + IPV interventionExperimentalThe protocol for number and timing of visits will be the same for both NFP+IPVI and Standard Care, as follows: weekly for the first four visits, every other week for the remainder of the pregnancy, every week for six weeks in the postpartum and every other week until the infant is 21 months old after which it is once a month for the last three months. We recognize that the intervention might prompt the nurse and mother to alter the regular visit schedule if IPV is present.
Receives: Behavioral: NFP + IPV intervention
NFP (standard care)No interventionThe NFP nurses currently receive some training regarding IPV, but it is minimal. Between intake and when the child is 3 months and 12 months old, there is a brief instruction that the nurse assess for IPV. If the client acknowledges current abuse when completing the Abuse Assessment Screen, the nurse should "assist her to evaluate threats to personal safety and make referrals as needed". There is a prompt to be mindful of client safety, and to make referrals as needed.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in WHO Quality of Life-BREF at 6, 12, 18, and 24 months

    Measured: Baseline, 3-, 6-,12-, 18-, and 24-month postpartum

Secondary outcomes (14)
  1. The Composite Abuse Scale (CAS)

    Validated 30-item research instrument that assesses exposure to physical, sexual and emotional abuse, harassment and combined severe abuse.

    Measured: Baseline, 3-, 6-,12-, 18-, and 24-month postpartum

  2. The Domestic Violence Survivor Assessment (DVSA)

    Based on Prochaska's Transtheoretical Model of Behaviour Change (also known as "stages of change") and was developed by Dienemann and colleagues to gain a better understanding of battered women's cognitive states during counseling.

    Measured: Baseline, 3-, 6-,12-, 18-, and 24-month postpartum

  3. PRIME-MD Patient Health Questionnaire (PHQ-9)

    Depression measure.

    Measured: Baseline, 3-, 6-,12-, 18-, and 24-month postpartum

  4. SPAN (Startle, Physiological arousal, Anger and Numbness)

    Post-Traumatic Stress Disorder measure.

    Measured: Baseline, 3-, 6-,12-, 18-, and 24-month postpartum

  5. The SF-12 (v. 2)

    Mental and Physical Health

    Measured: Baseline, 3-, 6-,12-, 18-, and 24-month postpartum

  6. The TWEAK

    Screening tool for alcohol abuse/dependency.

    Measured: Baseline, 3-, 6-,12-, 18-, and 24-month postpartum

  7. Drug Abuse Screening Tool (DAST)

    Prescription and Street Drug Use.

    Measured: Baseline, 3-, 6-,12-, 18-, and 24-month postpartum

  8. The Intimate Partner Violence Strategies Index (IPV Strategies)

    Specific actions women take to cope with violence.

    Measured: Baseline, 3-, 6-,12-, 18-, and 24-month postpartum

  9. The Childhood Experiences of Violence Questionnaire Short Form (CEVQ-SF)

    Childhood maltreatment

    Measured: 6-month postpartum

  10. The Childhood Trauma Questionnaire (CTQ)

    Childhood maltreatment.

    Measured: 6-month postpartum

  11. A modified version of the Health and Social Service Utilization questionnaire

    Assessment of service utilization.

    Measured: 6-,12-, 18-, and 24-month postpartum

  12. Child health outcomes

    Data regarding the following child health outcomes are gathered by maternal interview: 1) birth weight; 2) length of gestation; 3) injuries; 4) emergency department visits (including those that are injury-related); 5) hospitalizations; 6) immunizations; and 7) developmental delay.

    Measured: Outcomes 1 and 2 are assessed at infant birth, 3 to 7 will be assessed at 6-, 12-, 18-, 24-month postpartum

  13. Child Protection Service records

    Number of reports made, cases of confirmed child maltreatment, the type of maltreatment, the duration that cases were open, and whether children were placed in foster care or in custody of another family member.

    Measured: 24-month postpartum

  14. The Public Health Nurses' Responses to Women Who Are Abused

    Nurses' readiness to treat IPV. In the 20-item PHNR, nurses respond to one of two scenarios that resemble real-life experiences they would encounter in a postpartum home visit. The instrument measures nurses' thoughts, feeling and actions in response to identifying and responding to IPV. The PHNR has good internal consistency with an overall Cronbach alpha of 0.79.

    Measured: Collected from nurses at baseline, 12 and 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2011 (estimated)
  2. Study startMay 2011
  3. Primary completionMay 2015
  4. Study completionMay 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
492 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01372098
Sponsor's protocol ID
MacMillan_NFP_IPVI_RCT
Status last verified
Jun 2015
First submitted
9 Jun 2011
Last updated
9 Jun 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Kalra N, Hooker L, Reisenhofer S, Di Tanna GL, Garcia-Moreno C. Training healthcare providers to respond to intimate partner violence against women. Cochrane Database Syst Rev. 2021 May 31;5(5):CD012423. doi: 10.1002/14651858.CD012423.pub2.

    PubMed 34057734
  • Jack SM, Boyle M, McKee C, Ford-Gilboe M, Wathen CN, Scribano P, Davidov D, McNaughton D, O'Brien R, Johnston C, Gasbarro M, Tanaka M, Kimber M, Coben J, Olds DL, MacMillan HL. Effect of Addition of an Intimate Partner Violence Intervention to a Nurse Home Visitation Program on Maternal Quality of Life: A Randomized Clinical Trial. JAMA. 2019 Apr 23;321(16):1576-1585. doi: 10.1001/jama.2019.3211.

    PubMed 31012933

Questions about this trial

What is this clinical trial studying?

A study testing NFP + IPV intervention in people with Domestic Violence, run by McMaster University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in WHO Quality of Life-BREF at 6, 12, 18, and 24 months (time frame: Baseline, 3-, 6-,12-, 18-, and 24-month postpartum). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01372098, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in